Clinical Challenges

Herpes Simplex Virus-Related Oral Mucositis in Patients With Lymphoma

Maria Guerrero

Karen K. Swenson

herpes simplex virus, oral mucositis, lymphoma, immunocompromised patients
ONF 2014, 41(3), 327-330. DOI: 10.1188/14.ONF.327-330

A 58-year-old man named J.S. was diagnosed with non-Hodgkin lymphoma and underwent treatment with standard rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy. He presented to his local outpatient clinic for evaluation and laboratory tests on day 10 after cycle 3. During this visit, J.S. reported great difficulty opening his mouth with significant gingival and lingual pain when eating and drinking in spite of prophylactic oral care. Laboratory test results revealed a white blood cell count of 0.9 k/ul, hemoglobin level of 8.9 g/dl, platelets of 100 k/ul, serum creatinine level of 1 mg/dl, and blood urea nitrogen level of 29 mg/dl.

Jump to a section


    Brady, R.C., & Bernstein, D.I. (2004). Treatment of herpes simplex virus infections. Antiviral Research, 61, 73-81. doi:10.1016/j.antiviral.2003.09.006
    Camp-Sorrell, D., & Hawkins, R.A. (Eds.). (2006). Clinical manual for the oncology advanced practice nurse (2nd ed.). Pittsburgh, PA: Oncology Nursing Society.
    Cawley, M.M., & Benson, L.M. (2005). Current trends in managing oral mucositis. Clinical Journal of Oncology Nursing, 9, 584-592. doi:10.1188/05.CJON.584-592
    Chen, Y.K., Hou, H.A., Chow, J.M., Chen, Y.C., Hsueh, P.R., & Tien, H.F. (2011). The impact of oral herpes simplex virus infection and candidiasis on chemotherapy-induced oral mucositis among patients with hematological malignancies. European Journal of Clinical Microbiology and Infectious Diseases, 30, 753-759. doi:10.1007/s10096-010-1148-z
    Eilers, J., & Epstein, J.B. (2004). Assessment and measurement of oral mucositis. Seminars in Oncology Nursing, 20, 22-29. doi:10.1053/S0749-2081(03)00136-0
    Eilers, J., & Million, R. (2007). Prevention and management of oral mucositis in patients with cancer. Seminars in Oncology Nursing, 23, 201-212. doi:10.1016/j.sonen.2007.05.005
    Fitzmorris, K.L., Greene, J.N., Sandin, R.L., & Field, T. (2000). Recognition and management of herpes simplex mucositis in neutropenic patients. Infectious Medicine. Retrieved from
    Lalla, B.D., Sonis, S.T., & Peterson, D.E. (2008). Management of oral mucositis in patients with cancer. Dental Clinics of North America, 52, 61-77. doi:10.1016/j.cden.2007.10.002
    Negrin, R., Bedard, J., & Toljanic, J. (2014). Oral toxicity associated with chemotherapy. Retrieved from
    Salvaggio, M.R., Lutwick, L.I., Seenivasan, M., & Kumar, S. (2012). Herpes simplex. Retrieved from
    Sonis, S.T. (2004). Pathobiology of mucositis. Seminars in Oncology Nursing, 20, 11-15. doi:10.1053/S0749-2081(03)00134-7
    Treister, N.S. (2013). Chemotherapy-induced oral musositis clinical presentation. Retrieved from
    Vera-Llonch, M., Oster, G., Ford, C.M., Lu, J., & Sonis, S. (2007). Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Supportive Care in Cancer, 15, 491-496. doi:10.1007/s00520-006-176-9